•Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes
•The effect of early time-restricted eating on muscle damage-related biomarkers and anxiety in older men
•Performance validation and clinical application evaluation of fluorescent magnetic particle chemiluminescence method for the determination of sIgE
•The Effect of Hepatoprotectors on the Risk of Drug-induced Hepatitis in Pulmonary Tuberculosis Patients
•Effects of statins on major adverse cardiovascular events, metabolic and inflammatory parameters in patients with hepatitis B virus comorbid with cardiovascular disease